Publications by authors named "Zsofia Majlath"

Claim this Profile
P
Personality traits and psychological complaints under patients suffering from headaches.
Melinda Hal, Viktor Hal, László Vécsei, Anna Balog, Zsófia Majláth

Ideggyogy Sz· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of psychiatric comorbidities and stress-coping strategies on perceived quality of life in migraine.
Anna Petrovics-Balog, Zsófia Majláth, Lukács Melinda, Adrienn Holczer, Anita Must

Ideggyogy Sz· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on Laquinimod.
Zsofia Majlath, Adam Annus, Laszlo Vecsei

Curr Drug Targets· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin.
Zsofia Majlath, Izabella Obal, Laszlo Vecsei

CNS Neurol Disord Drug Targets· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.
Cecilia Rajda, Dániel Pukoli, Zsuzsanna Bende, Zsófia Majláth, László Vécsei

Int J Mol Sci· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
Zsófia Majláth, Nóra Török, József Toldi, László Vécsei

Curr Neuropharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.
Nóra Török, Zsófia Majláth, Ferenc Fülöp, József Toldi, László Vécsei

Curr Drug Metab· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.
Zsófia Majláth, József Toldi, Ferenc Fülöp, László Vécsei

Curr Med Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Migraine and neuropeptides" [Neuropeptides (2015) 19-30].
János Tajti, Délia Szok, Zsófia Majláth, Bernadett Tuka, Anett Csáti

Neuropeptides· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease.
Nóra Török, Zsófia Majláth, Levente Szalárdy, László Vécsei

Expert Opin Investig Drugs· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alleviation of pain in painful diabetic neuropathy.
János Tajti, Délia Szok, Zsófia Majláth, Anett Csáti, Anna Petrovics-Balog

Expert Opin Drug Metab Toxicol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising therapeutic agents for the treatment of Parkinson's disease.
Zsófia Majláth, Nóra Török, József Toldi, László Vécsei

Expert Opin Biol Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design.
Janos Tajti, Zsofia Majlath, Delia Szok, Anett Csati, Jozsef Toldi

Curr Pharm Des· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug targets of migraine and neuropathy: treatment of hyperexcitability.
László Vécsei, Zsófia Majláth, Anna Balog, János Tajti

CNS Neurol Disord Drug Targets· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine and neuropeptides.
János Tajti, Délia Szok, Zsófia Majláth, Bernadett Tuka, Anett Csáti

Neuropeptides· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Cecilia Rajda, Zsófia Majláth, Dániel Pukoli, László Vécsei

Int J Mol Sci· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Stress and the kynurenine pathway].
Zsófia Majláth, László Vécsei

Orv Hetil· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug safety in acute migraine treatment.
János Tajti, Zsófia Majláth, Délia Szok, Anett Csáti, László Vécsei

Expert Opin Drug Saf· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug safety and tolerability in prophylactic migraine treatment.
László Vécsei, Zsófia Majláth, Délia Szok, Anett Csáti, János Tajti

Expert Opin Drug Saf· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental disturbances in Parkinson's disease and related disorders: the role of excitotoxins.
Izabella Obál, Zsófia Majláth, József Toldi, László Vécsei

J Parkinsons Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NMDA antagonists as Parkinson's disease therapy: disseminating the evidence.
Zsófia Majláth, László Vécsei

Neurodegener Dis Manag· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.
Zsófia Majláth, József Toldi, László Vécsei

J Neural Transm (Vienna)· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kynurenines and other novel therapeutic strategies in the treatment of dementia.
Zsófia Majláth, János Tajti, László Vécsei

Ther Adv Neurol Disord· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurology in Hungary: past, present, and future.
Zsófia Majláth, András Ajtay, Dániel Bereczki, László Csiba, Sámuel Komoly

Neurology· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kynurenines in cognitive functions: their possible role in depression.
Imola Plangar, Zsofia Majlath, Laszlo Vecsei

Neuropsychopharmacol Hung· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis